Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 6—June 2022
CME ACTIVITY - Synopsis

Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017–2020

Thaidra GaufinComments to Author , Jill Blumenthal, Claudia Ramirez-Sanchez, Sanjay Mehta, David T. Pride, Joshua Fierer, and Jeffrey D. Jenks
Author affiliations: Sansum Clinic Infectious Diseases, Santa Barbara, California, USA (T. Gaufin); University of California San Diego, La Jolla, California, USA (J. Blumenthal, C. Ramirez-Sanchez, S. Mehta, D.T. Pride, J. Fierer); San Diego Veterans Affairs Medical Center, San Diego (S. Mehta, J. Fierer); Durham County Department of Public Health, Durham, North Carolina, USA (J.D. Jenks)

Main Article

Table 2

Variables associated with Shigella flexneri and Shigella sonnei Infection, San Diego, California, USA, March 1, 2017–May 31, 2020*

Patient variable Shigella flexneri, no. (%) Shigella sonnei, no. (%) p value
HIV positive 44 (68) 21 (43) 0.008
Sexual orientation, GBM/transgender woman 45 (85) 26 (68) 0.061
HAART use by persons living with HIV 40 (91) 15 (71) 0.065
PrEP use among HIV-negative 4 (80) 4 (57) 0.408
Unhoused 6 (8) 23 (40) <0.001
Methamphetamine use 16 (23) 26 (46) 0.006
Travel 11 (15) 9 (20) 0.008

*GBM, gay and bisexual man; HAART, highly active antiretroviral therapy; PrEP, preexposure prophylaxis.

Main Article

Page created: April 11, 2022
Page updated: May 23, 2022
Page reviewed: May 23, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external